Cargando…
Current status of silica-based nanoparticles as therapeutics and its potential as therapies against viruses
In the past decade, interest in nanoparticles for clinical indications has been steadily gaining traction. Most recently, Lipid Nanoparticles (LNP) have been used successfully to construct the SARS-CoV-2 mRNA vaccines for rapid pandemic response. Similarly, silica is another nanomaterial which holds...
Autores principales: | Tng, Danny Jian Hang, Low, Jenny Guek Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776486/ https://www.ncbi.nlm.nih.gov/pubmed/36566118 http://dx.doi.org/10.1016/j.antiviral.2022.105488 |
Ejemplares similares
-
Current Status of Dengue Therapeutics Research and Development
por: Low, Jenny G. H., et al.
Publicado: (2017) -
Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations
por: Djayanti, Krismala, et al.
Publicado: (2023) -
Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity
por: Tng, Danny Jian Hang, et al.
Publicado: (2021) -
Correction to: Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity
por: Tng, Danny Jian Hang, et al.
Publicado: (2023) -
Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
por: Tao, Yaoye, et al.
Publicado: (2020)